Achieve Life Sciences Inc expected to post a loss of 83 cents a share - Earnings Preview

Achieve Life Sciences

14/03/2023 20:09

* Achieve Life Sciences Inc  ACHV.OQ   ACHV.O  is expected
to show
a rise in quarterly revenue when it reports  results on March
16. 
    * The Seattle Washington-based  company is expected to
report
revenue of $100 thousand, according to the mean estimate from 5
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Achieve Life
Sciences Inc
is for a loss of 83 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Achieve
Life
Sciences Inc is $23​, above​ its last closing price of $4.28.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -1.14       -1.13      -1.35     Missed  -19.8
 Jun. 30 2022  -0.83       -0.83      -1.08     Missed  -29.5
 Mar. 31 2022  -0.79       -0.81      -0.80     Beat    1.5​
 Dec. 31 2021  -0.70       -0.69      -0.76     Missed  -9.9
 ​​Sep.        -1.14       -1.11      -0.71     Beat    36.2
 30 2021                                                
 Jun. 30 2021  -1.22       -1.22      -1.53     Missed  -25.2​
 Mar. 31 2021  -1.01       -1.03      -1.30     Missed  -26.6
 Dec. 31 2020  -1.25       -1.25      -1.11     Beat    11.6
 This summary was machine generated March 14 at 20:09 GMT.  All
figures in US dollars  unless otherwise stated